RE: I dont understand this one23 Jun 2015 13:46
Don’t think this one will ever achieve ‘blue sky’ status due to its simple hoovering up of developed products. Having said that, they don’t have the usual expense/problem/worries of introducing a drug to market. So, with a reasonable dividend, and potential growth/adoption of further drugs, what’s not to like. I'm in...